Ocugen Inc (OCGN)

Ocugen (OCGN) Stock Price & Analysis


OCGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.44 - $3.11
Previous Close$0.46
Average Volume (3M)7.42M
Market Cap
Enterprise Value$48.28M
Total Cash (Recent Filing)$76.72M
Total Debt (Recent Filing)$6.28M
Price to Earnings (P/E)-1.3
Aug 04, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding226,430,141
10 Day Avg. Volume12,283,966
30 Day Avg. Volume7,420,231
Standard Deviation1.00
Financial Highlights & Ratios
Price to Book (P/B)1.61
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.57
Price Target Upside817.93% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Ocugen Inc’s price range in the past 12 months?
Ocugen Inc lowest stock price was $0.44 and its highest was $3.11 in the past 12 months.
    What is Ocugen Inc’s market cap?
    Currently, no data Available
    When is Ocugen Inc’s upcoming earnings report date?
    Ocugen Inc’s upcoming earnings report date is Aug 04, 2023 which is in 68 days.
      How were Ocugen Inc’s earnings last quarter?
      Ocugen Inc released its earnings results on May 05, 2023. The company reported -$0.07 earnings per share for the quarter, beating the consensus estimate of -$0.108 by $0.038.
        Is Ocugen Inc overvalued?
        According to Wall Street analysts Ocugen Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Ocugen Inc pay dividends?
          Ocugen Inc does not currently pay dividends.
          What is Ocugen Inc’s EPS estimate?
          Ocugen Inc’s EPS estimate is -$0.08.
            How many shares outstanding does Ocugen Inc have?
            Ocugen Inc has 226,430,150 shares outstanding.
              What happened to Ocugen Inc’s price movement after its last earnings report?
              Ocugen Inc reported an EPS of -$0.07 in its last earnings report, beating expectations of -$0.108. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Ocugen Inc?
                Among the largest hedge funds holding Ocugen Inc’s share is Gotham Asset Management LLC. It holds Ocugen Inc’s shares valued at N/A.


                  Ocugen Stock Smart Score

                  The Ocugen stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Ocugen Inc

                  Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline of therapies includes OCU400, OCU410, OCU200, OCU100, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA.


                  Top 5 ETFs holding OCGN

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  Fidelity Nasdaq Composite Index ETF
                  Unusual Whales Subversive Republican Trading ETF
                  Up to five ETFs with an Outperform Smart Score that hold OCGN. The ETFs are listed according to market value of OCGN within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Organogenesis Holdings
                  PepGen Inc.
                  Kinnate Biopharma
                  Omega Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis